Severe Bronchoconstriction Caused by Administration of Rocuronium in a 3-Month-Old Infant: Case Report

We present the case of a 3-month-old infant with severe, persistent bronchoconstriction following administration of rocuronium. This observation raises awareness of a rare but potentially life-threatening reaction to neuromuscular blocking agents.

Automated summary

This case highlights the possibility of severe and persistent bronchoconstriction following the administration of neuromuscular blocking agents, serving as a reminder of the potentially life-threatening reactions that can occur.